Literature DB >> 15205571

Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells.

Massimo Montalto1, Nicola Maggiano, Riccardo Ricci, Valentina Curigliano, Luca Santoro, Fiorella Di Nicuolo, Fabio Maria Vecchio, Antonio Gasbarrini, Giovanni Gasbarrini.   

Abstract

BACKGROUND/AIMS: Non-steroidal anti-inflammatory drugs cause enterocyte damage inducing an increase of intestinal permeability. Tight junctions are the key structures in the permeability of the intestinal mucosa. ZO-1 is a tight junction associated protein considered a good marker of their integrity. It has been suggested that probiotics could play a protective role in the intestinal barrier function. We determined, in vitro, whether the heat-killed Lactobacillus acidophilus strain LB (LaLB) with its spent culture supernatant protects tight junctions of HT-29 cells from aspirin (ASA) damage.
METHODS: HT-29 cells were treated with ASA alone or ASA and LaLB with its spent culture supernatant together. Morphological alterations of tight junctions were evaluated by immunofluorescence using an anti-ZO-1 antibody. Moreover, a semiquantitative assay for ZO-1 was performed by Western blot.
RESULTS: Immunofluorescence analysis showed a fragmented and granulous ZO-1 staining, after ASA treatment. Using both ASA and LaLB with its spent culture supernatant together, we found a fine continuous linear web at cell-cell contacts similarly to control. Western blot revealed that ASA inhibited ZO-1 expression and LaLB with its spent culture supernatant counteracted this effect.
CONCLUSIONS: This pilot study shows, for the first time, the protective effect of LaLB with its spent culture supernatant on tight junctions from ASA damage. These results suggest that probiotics could play a role in the prevention of ASA-induced alterations of intestinal permeability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205571     DOI: 10.1159/000079152

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  29 in total

1.  Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria.

Authors:  Elizabeth Furrie; Sandra Macfarlane; George Thomson; George T Macfarlane
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

2.  Effects of probiotics supplementation on gastrointestinal permeability, inflammation and exercise performance in the heat.

Authors:  Cecilia M Shing; Jonathan M Peake; Chin Leong Lim; David Briskey; Neil P Walsh; Matthew B Fortes; Kiran D K Ahuja; Luis Vitetta
Journal:  Eur J Appl Physiol       Date:  2013-10-23       Impact factor: 3.078

3.  Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology.

Authors:  Linda Chia-Hui Yu; Jin-Town Wang; Shu-Chen Wei; Yen-Hsuan Ni
Journal:  World J Gastrointest Pathophysiol       Date:  2012-02-15

Review 4.  NSAID enteropathy: could probiotics prevent it?

Authors:  Massimo Montalto; Antonella Gallo; Antonio Gasbarrini; Raffaele Landolfi
Journal:  J Gastroenterol       Date:  2012-08-09       Impact factor: 7.527

Review 5.  Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.

Authors:  Antonella Gallo; Giovanna Passaro; Antonio Gasbarrini; Raffaele Landolfi; Massimo Montalto
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

6.  Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction.

Authors:  A Ait-Belgnaoui; W Han; F Lamine; H Eutamene; J Fioramonti; L Bueno; V Theodorou
Journal:  Gut       Date:  2006-02-28       Impact factor: 23.059

7.  Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function.

Authors:  Cong Dai; Stefano Guandalini; De-Hui Zhao; Min Jiang
Journal:  Mol Cell Biochem       Date:  2011-10-22       Impact factor: 3.396

8.  Probiotics and small bowel mucosa: Molecular aspects of their interactions.

Authors:  N Saulnier; M A Zocco; S Di Caro; G Gasbarrini; A Gasbarrini
Journal:  Genes Nutr       Date:  2006-06       Impact factor: 5.523

Review 9.  A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB.

Authors:  Vanessa Liévin-Le Moal
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

Review 10.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.